Marte G. Cameron

Kristiansand, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.

Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.

Journal: Journal of translational medicine

Published: July 15, 2022

Prospective case series of neuropathic cancer pain in patients treated with an EGFR-inhibitor.

Prospective case series of neuropathic cancer pain in patients treated with an EGFR-inhibitor.

Journal: Palliative medicine

Published: June 03, 2022

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.

Journal: Journal of translational medicine

Published: March 17, 2022

WITHDRAWN: Neuropathic Cancer Pain in Patients Treated With an EGFR-Inhibitor

WITHDRAWN: Neuropathic Cancer Pain in Patients Treated With an EGFR-Inhibitor

Journal: Journal of pain and symptom management

Published: June 16, 2021

Differential effects of epidermal growth factor receptor inhibitors in a single patient with neuropathic pain.

Differential effects of epidermal growth factor receptor inhibitors in a single patient with neuropathic pain.

Journal: BMJ case reports

Published: March 27, 2021

Relief of Neuropathic Pain Through Epidermal Growth Factor Receptor Inhibition: A Randomized Proof-of-Concept Trial.

Relief of Neuropathic Pain Through Epidermal Growth Factor Receptor Inhibition: A Randomized Proof-of-Concept Trial.

Journal: Pain medicine (Malden, Mass.)

Published: May 21, 2019

Oxaliplatin Plus Cetuximab: Are Uncertainties Unequivocally Settled?

Oxaliplatin Plus Cetuximab: Are Uncertainties Unequivocally Settled?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 03, 2019

Erratum to "Epithelial growth factor receptor (EGFR)-inhibition for relief of neuropathic pain-A case series" [Scand. J. Pain 4 (2013) 3-7].

Erratum to "Epithelial growth factor receptor (EGFR)-inhibition for relief of neuropathic pain-A case series" [Scand. J. Pain 4 (2013) 3-7].

Journal: Scandinavian journal of pain

Published: June 20, 2018

Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter study.

Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 23, 2016

Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain.

Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain.

Journal: British journal of anaesthesia

Published: October 18, 2015

Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study.

Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 12, 2015

Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review.

Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 08, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026